Skip to content
Screener

Contineum Therapeutics, Inc. CTNM Q3 2025 earnings

Reported October 30, 2025 · Before market open

EPS-$0.45Beat by $0.13
Revenue estimate$5.0M
EPS estimate-$0.58

Next report

Oct 29, 2026 (in a month)
Revenue estimate$5.7M
EPS estimate-$0.45

FAQ

When did Contineum Therapeutics, Inc. report Q3 2025 earnings?
Contineum Therapeutics, Inc. (CTNM) reported Q3 2025 earnings on October 30, 2025 before market open.
What were Contineum Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Contineum Therapeutics, Inc. reported eps of $-0.45 for Q3 2025.
Did Contineum Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.58 by $0.13.
How did Contineum Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 12.5% from $-0.40.
Where can I find Contineum Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001437749-25-032422) and the 10-Q periodic report (0001437749-25-032427) directly on SEC EDGAR. The filing index links above go to sec.gov.